Treating Tobacco Dependence at the Intersection of Diversity, Poverty, and Mental Illness: A Randomized Feasibility and Replication Trial

被引:23
|
作者
Hickman, Norval J., III [1 ]
Delucchi, Kevin L. [2 ]
Prochaska, Judith J. [3 ]
机构
[1] Univ Calif, Off President, Tobacco Related Dis Res Program, Oakland, CA 94606 USA
[2] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
[3] Stanford Univ, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA
关键词
NICOTINE REPLACEMENT THERAPY; EXPERT-SYSTEM INTERVENTION; SMOKING-CESSATION; PERCEIVED DISCRIMINATION; CIGARETTE-SMOKING; FAGERSTROM TEST; PUBLIC-HEALTH; SOCIAL-STATUS; DOUBLE-BLIND; SMOKERS;
D O I
10.1093/ntr/ntv034
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: In an ethnically-diverse, uninsured psychiatric sample with co-occurring drug/alcohol addiction, we evaluated the feasibility and reproducibility of a tobacco treatment intervention. The intervention previously demonstrated efficacy in insured psychiatric and nonpsychiatric samples with 20.0%-25.0% abstinence at 18 months. Methods: Daily smokers, recruited in 2009-2010 from psychiatric units at an urban public hospital, were randomized to usual care (on-unit nicotine replacement plus quit advice) or intervention, which added a Transtheoretical-model tailored, computer-assisted intervention, stage-matched manual, brief counseling, and 10-week post-hospitalization nicotine replacement. Results: The sample (N = 100, 69% recruitment rate, age M = 40) was 56% racial/ethnic minority, 65% male, 79% unemployed, and 48% unstably housed, diagnosed with unipolar (54%) and bipolar (14%) depression and psychotic disorders (46%); 77% reported past-month illicit drug use. Prior to hospitalization, participants averaged 19 (SD = 11) cigarettes/day for 23 (SD = 13) years; 80% smoked within 30 minutes of awakening; 25% were preparing to quit. Encouraging and comparable to effects in the general population, 7-day point prevalence abstinence for intervention versus control was 12.5% versus 7.3% at 3 months, 17.5% versus 8.5% at 6 months, and 26.2% versus 16.7% at 12 months. Retention exceeded 80% over 12 months. The odds of abstinence increased over time, predicted by higher self-efficacy, greater perceived social status, and diagnosis of psychotic disorder compared to unipolar depression. Conclusions: Findings indicate uninsured smokers with serious mental illness can engage in tobacco treatment research with quit rates comparable to the general population. A larger investigation is warranted. Inclusion of diverse smokers with mental illness in clinical trials is supported and encouraged.
引用
收藏
页码:1012 / 1021
页数:10
相关论文
共 50 条
  • [1] A Call for Inclusivity: The Feasibility of Engaging Patients with Serious Mental Illness and Cancer in a Randomized Trial
    Shaqour, Samar
    Thomas, Lauren
    Decker, Veronica
    Corveleyn, Amy
    Smith, Alexis
    Brown, Shukriyah
    Gorton, Emily
    Irwin, Kelly E.
    [J]. PSYCHO-ONCOLOGY, 2023, 32 : 42 - 42
  • [2] Feasibility of recruiting in prisons during a randomized controlled trial with people with serious mental illness
    Phillips, Jonathan
    Wilson, Amy Blank
    Villodas, Melissa L.
    Parisi, Anna
    Dohler, Ehren
    Givens, Ashley
    [J]. CLINICAL TRIALS, 2023, 20 (01) : 22 - 30
  • [3] The costs and effectiveness of different benefit designs for treating tobacco dependence: Results from a randomized trial
    Halpin, Helen Ann
    McMenamin, Sara B.
    Rideout, Jeffrey
    Boyce-Smith, Gifford
    [J]. INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2006, 43 (01) : 54 - 65
  • [4] Effectiveness and costs of different benefit designs for treating tobacco dependence: Results from a randomized trial
    Halpin, HA
    McMenamin, SB
    Rideout, J
    Boyce-Smith, G
    [J]. NICOTINE & TOBACCO RESEARCH, 2005, 7 (04) : 681 - 682
  • [5] Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease
    Foulds, J.
    Schmelzer, A. C.
    Steinberg, M. B.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (02) : 142 - 146
  • [6] Topiramate for treating alcohol dependence - A randomized controlled trial
    Johnson, Bankole A.
    Rosenthal, Norman
    Capece, Julie A.
    Wiegand, Frank
    Mao, Lian
    Beyers, Karen
    McKay, Amy
    Ait-Daoud, Nassima
    Anton, Raymond F.
    Ciraulo, Domenic A.
    Kranzler, Henry R.
    Mann, Karl
    O'Malley, Stephanie S.
    Swift, Robert M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (14): : 1641 - 1651
  • [7] Pharmacotherapy treatments for tobacco dependence among smokers with mental illness or addiction
    Williams, JM
    Hughes, JR
    [J]. PSYCHIATRIC ANNALS, 2003, 33 (07) : 457 - 466
  • [8] Tobacco dependence counseling in a randomized multisite clinical trial
    Croghan, Ivana T.
    Trautman, Judith A.
    Winhusen, Theresa
    Ebbert, Jon O.
    Kropp, Frankie B.
    Schroeder, Darrell R.
    Hurt, Richard D.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2012, 33 (04) : 576 - 582
  • [9] Treating tobacco dependence to aid re-employment among job-seekers: A randomized controlled trial
    Prochaska, Judith J.
    Brown-Johnson, Cati
    Baiocchi, Michael
    Lazaro, Adrienne S.
    Chieng, Amy
    Stinson, Sarah
    Anzai, Nicole
    [J]. PREVENTIVE MEDICINE, 2020, 141
  • [10] Intervention for tobacco dependence among people with a psychotic illness: Randomized controlled trial with one-year outcome
    Richmond, RL
    Baker, A
    Haile, M
    Carr, V
    Lewin, T
    Wilhelm, K
    Taylor, R
    Jansons, S
    [J]. NICOTINE & TOBACCO RESEARCH, 2005, 7 (04) : 681 - 681